
|Slideshows|May 31, 2018
New FDA Warning
Author(s)James Phelps, MD
A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.
Advertisement
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves First At-Home Brain Stimulation Device for Treatment of Depression
2
Trontinemab Shows Promise for Treatment of Alzheimer Disease in New Data at CTAD
3
An Update on the Role of Valproate in Bipolar Disorder
4
Colors of the Year for 2026: Which Color Would You Choose for Its Psychological Benefits?
5














